Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
AIDS (London, England)|July 16, 2021
The impact of viraemia on inflammatory biomarkers and CD4+ cell subpopulations in HIV-infected children in sub-Saharan AfricaAndrew J Prendergast, Alexander J Szubert, Godfrey Pimundu, et al.
The Journal of Antimicrobial Chemotherapy|September 20, 2024
Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIVLufina Tsirizani, Shaghayegh Mohsenian Naghani, Hylke Waalewijn, et al.
BMC Pediatrics|March 8, 2025
Immune response and associated factors to Hepatitis B vaccination among children under five attending care at mulago hospitalAndrew Kimera, Joseph Rujumba, Cynthia Kuteesa Ndikuno, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 14, 2023
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 TrialHylke Waalewijn, Alexander J Szubert, Roeland E Wasmann, et al.
Nature Communications|June 20, 2026
NK cell dysregulation may potentiate cardiovascular disease in adolescents with perinatally acquired HIV on antiretroviral therapyMario Alles, Manuja Gunasena, Aaren Kettelhut, et al.
Journal of Graduate Medical Education|February 21, 2025
GHEARD: An Open-Access Modular Curriculum to Incorporate Equity, Anti-Racism, and Decolonization Training Into Global Health EducationAmy R L Rule, Heather A Haq, Adelaide Barnes, et al.
BMC Medical Research Methodology|February 21, 2022
Borrowing information across patient subgroups in clinical trials, with application to a paediatric trialRebecca M Turner, Anna Turkova, Cecilia L Moore, et al.
The New England Journal of Medicine|July 21, 2017
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in AfricaJames Hakim, Victor Musiime, Alex J Szubert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2023
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL TrialTom G Jacobs, Vivian Mumbiro, Uneisse Cassia, et al.
Trials|June 27, 2022
Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trialPablo Rojo, Cinta Moraleda, Alfredo Tagarro, et al.
Pageof 16